LONDON, May 22, 2024 /PRNewswire/ -- Qinecsa
Solutions (Qinecsa), specialists in technology-led end-to-end
pharmacovigilance solutions, will host an expert discussion on
post-marketing safety surveillance, diving deeply into the
intricate world of medical devices and drug-device combination
products. This expert-led online webinar will take place
Wednesday, May 29, 2024, with a
choice of three sessions.
In this second part online seminar, industry expert Veronika
Valdova will explore the reporting essentials and obligations
associated with the post-marketing safety surveillance of medical
devices and drug-device combination products in both the EU and
USA markets. This will build upon
the foundation set in an earlier online seminar, exploring key EU
regulatory requirements, integration challenges, and actionable
steps for building resilient processes to support combined drug and
device portfolios within primarily pharma-focused
organizations.
This online seminar will guide participants through current
trends and challenges in the industry, offering valuable insights
into best practices and regulatory expectations to navigate the
complexities of safety surveillance and ensure compliance with
international standards.
Participants will come away with a greater understanding
of:
- Drug-Device and Combination Products – both in Europe and the U.S.
- Reporting Essentials and Obligations
- Essential Procedures to Cover
- Comparison of Reporting Requirements in the EU vs the U.S.
- Current Trends and/or Challenges
- Best Practices
For more information on this free to attend Qinecsa webinar, and
to register, visit Webinar: Navigating Post-Marketing Safety
Surveillance - Qinecsa
Save the Date: Wednesday, May
29th.
- Session 1: 6am ET |
12pm CE
- Session 2: 10am ET |
4pm CET
- Session 3: 2pm ET |
8pm CET.
To connect with Qinecsa, visit www.qinecsa.com
About Qinecsa Solutions
Qinecsa are specialists in technology led end-to-end
pharmacovigilance solutions. We are trusted, global partners
bringing together best-in-class technology and scientific expertise
to connect life science companies to the right safety solutions.
Through our unique insight into the challenges of
pharmacovigilance, we have created industry-leading, end-to-end
solutions for capturing, managing, and evaluating drug safety data,
more efficiently and accurately. Working with life science
companies we drive progress to continue protecting lives.
For more information visit: www.qinecsa.com
View original
content:https://www.prnewswire.co.uk/news-releases/qinecsa-host-industry-discussion-on-navigating-post-marketing-safety-surveillance-of-medical-devices-and-drug-device-combination-products-eu-and-usa-302152035.html